American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
27.75
+0.54 (1.98%)
Dec 20, 2024, 4:00 PM EST - Market closed
American Healthcare REIT Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for AHR stock have an average target of 25.25, with a low estimate of 14 and a high estimate of 31. The average target predicts a decrease of -9.01% from the current stock price of 27.75.
Analyst Consensus: Buy
* Price targets were last updated on Nov 18, 2024.
Analyst Ratings
The average analyst rating for AHR stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $28 → $30 | Buy | Maintains | $28 → $30 | +8.11% | Nov 18, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $27 → $29 | Strong Buy | Maintains | $27 → $29 | +4.50% | Nov 15, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $27 → $31 | Strong Buy | Maintains | $27 → $31 | +11.71% | Sep 24, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $22 → $27 | Strong Buy | Maintains | $22 → $27 | -2.70% | Sep 20, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $18 → $30 | Buy | Maintains | $18 → $30 | +8.11% | Sep 20, 2024 |
Financial Forecast
Revenue This Year
2.09B
Revenue Next Year
2.24B
from 2.09B
Increased by 6.99%
EPS This Year
0.02
from -1.08
EPS Next Year
0.27
from 0.02
Increased by 1,666.67%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 2.2B | 2.6B | 2.7B |
| Avg | 2.1B | 2.2B | 2.4B |
| Low | 2.0B | 2.0B | 2.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 23.0% | 19.8% |
| Avg | - | 7.0% | 9.0% |
| Low | - | -2.2% | -2.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.04 | 0.35 | 0.29 |
| Avg | 0.02 | 0.27 | 0.28 |
| Low | -0.01 | 0.20 | 0.27 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 2,187.1% | 9.8% |
| Avg | - | 1,666.7% | 5.7% |
| Low | - | 1,193.7% | 2.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.